Beihai Gofar Chuanshan Biological Co (SHSE:600538) Revenue: ¥334.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600538 Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
55 GF Score
Price ¥5.21
GF Value ¥4.70
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Beihai Gofar Chuanshan Biological Co Revenue?

Beihai Gofar Chuanshan Biological Co SHSE:600538 55 Revenue is ¥334.0 Mil as of Jun. 2026. GuruFocus rates SHSE:600538 with a GF Score™ of 55/100 and a GF Value™ of ¥4.70 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Beihai Gofar Chuanshan Biological Co's revenue for the three months ended in Jun. 2026 was ¥76.9 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ¥334.0 Mil. Beihai Gofar Chuanshan Biological Co's Revenue per Share for the three months ended in Jun. 2026 was ¥0.14. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.64.

Warning Sign:

Beihai Gofar Chuanshan Biological Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Beihai Gofar Chuanshan Biological Co was -3.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -11.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -6.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Beihai Gofar Chuanshan Biological Co's highest 3-Year average Revenue per Share Growth Rate was 41.60% per year. The lowest was -25.40% per year. And the median was -4.90% per year.


Beihai Gofar Chuanshan Biological Co  (SHSE:600538) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Beihai Gofar Chuanshan Biological Co Revenue Related Terms


Beihai Gofar Chuanshan Biological Co Revenue Historical Data

* Premium members only.

The historical data trend for Beihai Gofar Chuanshan Biological Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beihai Gofar Chuanshan Biological Co Revenue Chart

Beihai Gofar Chuanshan Biological Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 424.72 459.68 369.16 340.47 328.24

Beihai Gofar Chuanshan Biological Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.12 85.34 89.17 82.65 76.89

SHSE:600538 vs CTVA, CF, MOS: Revenue Comparison

For the Agricultural Inputs subindustry, Beihai Gofar Chuanshan Biological Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beihai Gofar Chuanshan Biological Co Revenue vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Beihai Gofar Chuanshan Biological Co's Revenue distribution charts can be found below:

* The bar in red indicates where Beihai Gofar Chuanshan Biological Co's Revenue falls into.


SHSE:600538
55GF Score
Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beihai Gofar Chuanshan Biological Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥334.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ¥334.0 Mil mean?
Beihai Gofar Chuanshan Biological Co (SHSE:600538) has a Revenue of ¥334.0 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors.
Is Beihai Gofar Chuanshan Biological Co's Revenue too high?
Beihai Gofar Chuanshan Biological Co's current Revenue is ¥334.0 Mil. Overall, Beihai Gofar Chuanshan Biological Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beihai Gofar Chuanshan Biological Co's Revenue compare to CTVA and CF?
Beihai Gofar Chuanshan Biological Co's Revenue of ¥334.0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Agriculture company?
A good Revenue depends on the Agriculture industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. Beihai Gofar Chuanshan Biological Co's current Revenue is ¥334.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beihai Gofar Chuanshan Biological Co stock overvalued right now?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co (SHSE:600538) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.70, compared to a current price of ¥5.21 — trading 10.9% above its estimated fair value. The current Revenue is ¥334.0 Mil. Beihai Gofar Chuanshan Biological Co's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Beihai Gofar Chuanshan Biological Co (SHSE:600538), the current Revenue is ¥334.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beihai Gofar Chuanshan Biological Co (SHSE:600538) Overvalued in 2026?

Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co stock appears to be overvalued. The current stock price of ¥5.21 is trading 10.9% above its estimated GF Value™ of ¥4.70. GuruFocus considers Beihai Gofar Chuanshan Biological Co to be Modestly Overvalued.

Key valuation signals for SHSE:600538:

  • Revenue: ¥334.0 Mil
  • GF Value™: ¥4.70 vs. price of ¥5.21 (10.9% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beihai Gofar Chuanshan Biological Co Business Description

Address No. 3, Beibuwan Middle Road, Guangxi Zhuang Autonomous Region, Beihai, Guangxi, CHN, 536000
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
55GF Score

Get the complete analysis for SHSE:600538

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.21
Price
¥4.70
GF Value